The primary objective of the study is to address any dietary
issues and modify your behaviour. The relationship between your thoughts,
feelings, and behaviours is examined in therapy. The disease known as bulimia
nervosa, which is typified by purging and binge eating, usually starts in
adolescence and peaks at the age of 18. Radioactive ligands are used in
positron emission tomography (PET) and single photon emission computed
tomography (SPECT) to investigate the distribution of neurotransmitter
receptors and glucose metabolism. The ratio of female to male patients varies
from 10:1 to 20:1, with a lifetime frequency of 3 per cent. The majority of
bulimic individuals also suffer from other mental illnesses, such as depression
or anxiety. Additionally, there is a correlation between substance misuse and
promiscuity. Bulimia nervosa was initially identified as a "chronic phase
of anorexia nervosa" in 1979 by British psychiatrist Gerald Russell. The
main goal of treatment is to get the patient to stop bingeing and purging. It
has been demonstrated that selective serotonin reuptake inhibitors, like
sertraline, citalopram, and fluoxetine, lessen bulimia nervosa symptoms. During
this stage, patients overeat and resort to compensatory methods such as
self-induced vomiting, laxatives, or extended periods of deprivation. Episodes
of bingeing and purging that happen at least once a week for three months are
usually linked to a diagnosis of bulimia. Even sometimes engaging in purging
and bingeing can be hazardous and necessitate medical treatment. The more often
the episodes occur, the worse the bulimia gets. To treat bulimia, family
therapy and individual treatment are commonly employed. We go over the
aetiology, epidemiology, current treatment, and state of bulimia nervosa in
this review study. Future counseling-based research in our nation or state will
evaluate patients' physical and mental health and generate more precise data on
bulimia nervosa and its treatment, thanks to the assistance of our colleagues.
Author(s) Details
Yash Srivastav
Azad Institute of Pharmacy & Research, Lucknow, U.P., India.
Sajjad Alam
Azad Institute of Pharmacy & Research, Lucknow, U.P., India.
Please see the book here:- https://doi.org/10.9734/bpi/mmrnp/v3/1512
No comments:
Post a Comment